Transcription
058430 2017 CPDD Plenary Brochure (5-23-17) Layout 1 5/23/17 11:14 AM Page 1Plenary ProgramandCPDD 2018 AwardeesSunday, June 10, 2018 at 8:30 AM - 11:00 AMHilton San Diego Bayfront HotelIndigo BCFGSan Diego, CA
058430 2017 CPDD Plenary Brochure (5-23-17) Layout 1 5/23/17 11:14 AM Page 2NATHAN B. EDDY MEMORIAL 985198619871988198919901991199219931994Maurice SeeversHarris IsbellAbraham WiklerWilliam MartinHans KosterlitzE. Leong WayAvram GoldsteinEverette MayVincent DoleMarie NyswanderEric SimonRaymond HoudeLouis HarrisHarold KalantClifton K. HimmelsbachAlbert HerzLeo E. HollisterCharles SchusterPhillip S. PortogheseAkira E. TakemoriJoseph V. BradyLee N. RobinsJerome H. JaffeMENTORSHIP 011201220132014201520162017Robert L. BalsterJames H. WoodsConan KornetskyCharles R. SchusterE. Leong WayLinda A. DykstraJames C. AnthonyScott E. LukasJoseph V. BradyGeorge BigelowCharles O’BrienStephen G. HoltzmanKathryn A. CunninghamJames SorensenMichael T. BardoMichael A. NaderKenner C. RiceStephen erbert D. KleberGriffith EdwardsMartin W. AdlerJohn W. LewisMary Jeanne KreekWilliam L. DeweyKenner C. RiceHorace H. LohCharles P. O’BrienJames H. WoodsConan KornetskyF. Ivy CarrollJack H. MendelsonNancy K. MelloBilly R. MartinRobert L. BalsterTheodore CiceroMichael J. KuharEdward M. SellersLinda DykstraNora D. VolkowRoland GriffithsWarren K. BickelWalter LingMARTIN & TOBY ADLERDISTINGUISHED SERVICE 0142015Richard A. MillsteinAlan I. LeshnerFrancis Vocci Jr.Charles O’KeeffeIan P. StolermanRichard M. EisenbergJonathan B. KamienEllen B. GellerGeoffrey K. MumfordWilliam L. DeweyJack HenningfieldPatrick J. KennedyGeneral Barry R. McCaffrey (Ret.)David ShurtleffCora Lee Wetherington
I 058430 2017 CPDD Plenary Brochure (5-23-17) Layout 1 5/23/17 11 :14 AM Page 3JOSEPH COCHIN YOUNG INVESTIGATOR 998199920002001Michael BozarthFrankPorrecaErrol B. De SouzaThomas KostenRichard RothmanJeffrey M. WitkinStephen HigginsRichard W. FoltinWarren K. BickelToni ShippenbergLisa H. GoldS. Stevens NegusSari IzenwasserLeslie AmassSharon WalshS. Barak CaineJ. MICHAEL 0032004200620082010201120132016Edward C. TocusMarvin SnyderArthur E. JacobsonHans HalbachBenyPrimmJack D. BlaineRao RapakaRoy W. PickensRoger BrownRichard L. HawksRonald BradyJoseph FrascellaRita LiuBetty TaiCora Lee WetheringtonSteven W. GustRedonna ChandlerMinda 0132014201520162017Laura Sim-SelleyAndrew CoopSandra D. ComerThomas E. EissenbergJames K. RowlettChristopherPierceNancy PetryHendree JonesLaura BohnDavid JentschThomas E. PrisinzanoJoshua A. LileWilliam StoopsC. Debra Furr-HoldenAdam LeventhalJun-Xu LiMatthew BanksCPDDINIDAMEDIA 008200920102011201220132014201520162017Katie McCabeJames BurkeRiester RobbSean ClarkinCarlos Davila RinaldiMichael MassingDavid T. CourtwrightAddiction StudiesProgram for JournalistsPeter ReuterBrian VastagHarvey WeissJohn Hoffman, Susan Froemke,Sheila NevinsWilliam Cope MoyersNancy D. CampbellAllan BrandtJustin HuntDirk HansonDavid SheffCharles Evans, Jr.Jeff Foote, Nichole Kosanke,Carrie W ilkensBess O'BrienSam QuinonesPfenary Proaram8:30 WelcomeCPDD President Alan J. Budney8:45 Celebrating the 80th Annual Scientific Meeting of theCommittee/College on Problems of DrugDependence Loretta P. Finnegan, CPDD ExecutiveOfficer9:15 Presentation of the Stephen G. Holtzman Travel Award for PreclinicalInvestigators to Lais F. BerraIntroduction by Alan J. Budney9:20 Presentation of the CPDD/NIDA Media Award to Maia SzalavitzIntroduction by Meg Chisolm9:35 Presentation of the Martin & Toby Adler Distinguished Service AwardIntroduction by Loretta Finnegan9:40 Presentation of the J. Michael Morrison Award to Ivan D. MontoyaIntroduction by Francis Levin9:45 Presentation of the Joseph Cochin Young Investigator Award toKelly DunnIntroduction by Maxine Stitzer9:50 Presentation of the Mentorship4ward to Leonard HowellIntroduction by Lais F. Berra9:55 Presentation of the Innovator Award to Thomas PrisinzanoIntroduction by Christopher Cunningham10:05 Presentation of the Nathan B. Eddy Award to Alex MakriyannisIntroduction by Thomas PrisinzanoI0:15Nathan B. Eddy LectureCannabinoid Receptors, Their Structures and FunctionsAlex Makriyannis, Northeastern University, Boston, MA
I 058430 2017 CPDD Plenary Brochure (5-23-17) Layout 1 5/23/17 11 :14 AM Page 4CPDD/NIDA MEDIA AWARDMaia SzalavitzBest Selling Author, JournalistMaia Szalavitz is the author of the New York Times bestseller, UnbrokenBrain: A Revolutionary New Way of Understanding Addiction. She haswritten about addiction for three decades for major publicationsincluding the New York Times, the Washington Post, ScientificAmerican, the Atlantic and many others. She is author or co-author of sixother books and writes a twice-monthly column for VICE on drugs and aregular column for The Guardian on inequality. Szalavitz is aninvestigative reporter for Time magazine and since 2004 has been a seniorfellow at George Mason University's media watchdog group STATS.org.In 2009, Szalavitz partnered with Brent W. Jeffs and released Lost Boy, abiography of Jeffs's life in the Fundamentalist Church of Jesus Christ ofLatter Day Saints. In Spring 2016, Unbroken Brain: A Revolutionary NewWay of Understanding Addiction was published by St. Martin's Press. Shewas a 2015 Soros Media fellow, which supported her in writing this book.NATHAN B. EDDY MEMORIAL AWARDAlexandros Makriyannis, Ph.D.George Behrakis Chair of Pharmaceutical BiotechnologyFounder and Director of the Center for Drug DiscoveryNortheastern University, Boston, eutical Biotechnology at Northeastern University, Boston,MA, and is the Founder and Director of the Center for DrugDiscovery. He is a highly successful medicinal chemist and iswellrecognizednationally andinternationallyforhisimportantcontributionsin endocannabinoid research. Thisrelatively newly characterized biochemical system, where he played animportant role in its discovery, regulates many n,addiction,immunomodulation and cognition. Over the past four decadeshis laboratory has designed and synthesized some of the keypharmacological endocannabinoid probes that are widely used andserve as leads for the development of new medications. Hehas also made important contributions aimed at understandingthe molecular basis of cannabinoid activity. He has been a creativepioneer in the field of chemical biology where he combined the useof medicinal chemistry, biochemistry,molecularbiology,andbiophysics. His work is recognized for its high level of originality.Some of his compounds are in advanced preclinical trials for thetreatmentof metabolic disorders andliverfunction,neuropathicpain,addiction,and neurodegenerative diseases.Dr. Makriyannis has been a member of CPDD since 1997.
I 058430 2017 CPDD Plenary Brochure (5-23-17) Layout 1 5/23/17 11 :14 AM Page 4MENTORSHIP AWARDLeonard Howell, Ph.D.Professor Emeritus, Emory University, Atlanta, GADr. Leonard Howell received his Ph.D. with training in experimentalpsychology, biochemistry and physiology from the Georgia Institute ofTechnology. Following postdoctoral training in psychobiology at Harvard MedicalSchool, he accepted a faculty position at Emory University where he spent his entireprofessional career and is currently professor emeritus. He most recently servedas Associate Director of Scientific Programs, Chief of the Division ofNeuropharmacology and Neurologic Diseases and Director of the ImagingCenter, Yerkes National Primate Research Center, and Professor of Psychiatryand Behavioral Sciences and Professor of Pharmacology, Emory UniversitySchool of Medicine. His research program at Emory for over 30 years focused onthe neuropharmacology of abused stimulants and included basic neurobiologicalstudies of drug mechanism as well as medications development. Theprogram was translational in its focus and bridged preclinical, nonhuman primatemodels with therapeutic applications in humans. He was recognized for hiscontributions with an NIH MERIT Award (2007-2016) and a Senior ResearchScientist and Mentorship Award (2012-2017) from the National Institute on DrugAbuse. He has served on several committees within the College including 2003-06), the Committee on Abuse Liability Testing (2006-10), and the ProgramCommittee (2010-2013), and also served on the Board of Directors(2009-2013). Dr. Howell has regularly attended as an active participant in theannual meetings since joining the College in 1993. He currently is Past-President,a member of the Executive Committee and the Board of Directors and a Fellow ofthe College.MARTIN & TOBY ADLERDISTINGUISHED SERVICE AWARDBertha Madras, Ph.D.Professor of PsychobiologyHarvard Medical School, Boston, MABertha Madras is Professor of Psychobiology, Harvard Medical School, and directsthe Lab of Addiction Neurobiology at McLean Hospital. Her laboratory discoveredkey targets of drugs in primate brain, developed novel imagingagents and identified naturalistic primate models of human-based genetic disorders.With collaborators, she received 19 U.S. and 27 international patents. She is editor ofseveral text books, developed the first addictions course (elective) for HMS students(1991), created the Cell Biology of Addictions Course at Cold Spring HarborLaboratory, and a Museum exhibit, CD (licensed by Disney), Changing your . As Deputy Director for Demand Reduction in the White HouseOffice of National Drug Control Policy, Executive Office of President, she catalyzedScreening, Brief Intervention, Referral to Treatment (SBIRT) services nationally. In2017, she served on President Trump's 6-member Commission on Combating DrugAddiction and the Opioid Crisis, and marshalled the final Commission report. TheWorld Health Organization commissioned her to write Update of Cannabis and itsMedical Use and she served as a panelist for the Vatican Pontifical Academy ofSciences assembly: "Narcotics: Problems and Solutions of this Global Issue". Shereceived an NIH MERIT award, NIDA Public Service Award, American Academy ofAddiction Psychiatry Founders' Award, among others. The Better World Report(2006) cited her brain imaging invention as "one of 25 technology transfer(university to industry) innovations that changed the world". A member of CPDDsince 1989, Dr. Madras served on the CPDD Board of Directors from 1999 - 2003.
I 058430 2017 CPDD Plenary Brochure (5-23-17) Layout 1 5/23/17 11 :14 AM Page 4J. MICHAEL MORRISON AW ARDIvan D. Montoya, M.D. M.P.H.Director, Division of Therapeutics and Medical ConsequencesThe National Institute on Drug Abuse, Bethesda, MDDr. Montoya is the Acting Director of the Division ofTherapeutics and Medical Consequences (DTMC) of the NationalInstitute on Drug Abuse (NIDA). He received an M.D. from theUniversity of Antioquia (Colombia), a Masters in Public Health fromThe Johns Hopkins School of Public Health, and completedresidency training in Psychiatry at the University of Antioquia andthe University of Maryland Hospital (Baltimore). He has beenFulbright Fellow at The Johns Hopkins School of Public Health,Visiting Foreign Fellow at the Intramural Research Program ofNIDA, Consultant for the Pan American Health Organization, andDirector of the Practice Research Network of the AmericanPsychiatric Association. He leads a large program of research atNIDA that supports the development of psychosocial andpharmacological treatments for Substance Use and AddictionDisorders. He has published extensively in the areas of etiology,prevention, treatment (pharmacological and non-pharmacological),and medical consequences of drug abuse. He recently was the editorof a book summarizing the science on biologics (vaccines,monoclonal antibodies, and enzymes) to treat substance use disorders.JOSEPH COCHINYOUNG INVESTIGATOR AWARDKelly Dunn, Ph.D., Associate ProfessorBehavioral Pharmacology Research UnitJohns Hopkins School of Medicine, Baltimore, MDKelly Dunn, earned BA' s in Psychology and Philosophy fromOswego State University and an MS in Applied Biopsychologyfrom the University of New Orleans. In 2005, she joined theUniversity of Vermont to work with Stacey Sigmon on randomizedcontrolled trials (RCT) of contingency management for smokingcessation among opioid-use disorder (OUD) patients andbuprenorphine taper durations in prescription opioid users. In 2009,she earned her PhD and joined the Behavioral PharmacologyResearch Unit in the Johns Hopkins School of Medicine as apostdoctoral fellow. Here, she worked with Ken Silverman in hisTherapeutic Workplace model of abstinence reinforcement andwith George Bigelow and Eric Strain on several RCTs evaluatingmedications for opioid and alcohol use disorders. She joined theBPRU as an Instructor in 2011 and has since been promoted toAssistant (2012) and Associate (2016) Professor. Dr. Dunn has beenthe PI of 5 NIDA-funded grants, all of which focus on OUD. Shehas developed a web-based opioid overdose intervention, is piloting amethod to treat pain in OUD patients, and is conducting 3 blinded ROIhuman laboratory studies examining OUD mechanisms. She has beencontinuously appointed to different CPDD committees for the past 10years, and is the incoming Chair of the CPDD Program Committee.She is also currently completing her MBA.
2004 Ronald Brady 2005 Brian Vastag 9:50 Presentation of the Mentorship4ward to Leonard Howell 2006 Joseph Frascella 2006 Harvey Weiss Introduction by Lais F. Berra 2008 Rita Liu 2007 John Hoffman, Susan Froemke, . Dr. Makriyannis has been a member of CPDD since 1997. I 058430 2017 CPDD Plenary Brochure (5-23-17)_Layout 1 5/23/17 11 :14 AM .
